Biomedical subjects
Publications and source records attributed to H Joos.
Malacoplakia of the kidney is a very rare disease, and in two-thirds of the cases the lower urinary tract is also affected. Malacoplakia of the urinary tract affects primarily the bladder and secondarily the distal ureter, rarely the kidney.
The effects of a combination of medroxyprogesterone acetate and testosterone enanthate, on the exocrine and endocrine testicular function were examined in adult men. The treatment was carried out with 2 different regimens and lasted for 8 months. Group I received an initial injection of 1000 mg medroxyprogesterone acetate and 500 mg testosterone enanthate followed by monthly maintenance dose of 150 mg medroxyprogesterone acetate and 500 mg testosterone enanthate. In group II, after an initial high dose of 1000 mg medroxyprogesterone acetate and 250 mg testosterone enanthate treatment was given as biweekly injections of 75 mg medroxyprogesterone acetate and 250 mg testosterone enanthate. Complete spermatogenic arrest of variable duration was achieved in all 9 subjects enrolled. Restoration of spermatogenesis occurred in both groups, in a few cases during the treatment, and there was a delay of full recovery of sperm counts up to 5 months after cessation of therapy. None of the subjects enrolled in this study complained of decrease in libido or change in sexual behaviour. Clinical evaluation and measurements of various urine and serum components revealed no significant changes during the treatment period. The dosage and the different administration schedule of the hormone combination described here was inadequate to maintain azoospermia in all subjects during treatment.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Erwinia herbicola CHS1065 produces antifungal compounds highly related to herbicolin A. In 11 Tn5 mutants that have lost the antifungal activity, the transposon insertion is located on a 170-kb plasmid present in CHS1065. This plasmid was designated pHER1065. When analyzing these antifungal mutants, it was found that the genes for the biosynthesis of the antifungal compounds were organized in at least two clusters on pHER1065. Upon insertion of the aphII gene of Tn5 and genes for plasmid mobilization in pHER1065, the plasmid could be stably introduced into Escherichia coli. All the E. coli exconjugants expressed an antifungal activity that was quantitatively and qualitatively comparable to the activity produced by E. herbicola CHS1065. Amino acid analysis and molecular weight determinations of the antifungal compound produced by CHS1065 were identical to those of herbicolin A.
Explore the source record for details and available documents.